Pricing

Renalytix

0 followers

‌

Renalytix (LSE: RENX) (NASDAQ: RNLX) is the founder and global leader in the new field of bioprognosis™ for kidney health.

Industries

Biotechnology

Headquarters

New York, United States

Employees

51-200

Links

Org chart

James McCullough

CEO

James McCullough

Collapse

Co-Founder

Co-Founder

CTO

Chief Medical Officer

Jed Fulk

Vice President Of Sales

Anna Flynn

Director, Quality System Compliance And Eh&s

Elise Wilfinger

Senior Vice President, Global Brand Strategy & Marketing Officer

Anita M.

Lab Technical Supervisor

Azadeh Zabetian

Senior Medical Science Liaison

Christopher Woytovich

Clinical Laboratory Scientist (cls)

Katherine Edwards PhD

Senior R&d Scientist

Noor Alyassin, MD

Research Assistant

Kate Brennan, CFA

Senior Manager, Strategic Finance

Christopher Scott

Chief Operating Officer

Justin DiVenuta

Regional Sales Director

Tony McNicholas

Staff Data Engineering And Data Science

Joe Fraas, MBA

Regional Sales Director

Teams

+11

Management Team

14 members

Healthcare and Clinical Science

7 members

Leadership Team

3 members

Sales Team

3 members

Product Management and Development Team

4 members

Similar companies

Ardelyx

3 followers

Agilent Technologies

63 followers

PathAI

56 followers

AbbVie

167 followers

Dragonfly Therapeutics

1 follower

Invivyd

1 follower

Sapphire Ventures

19 followers

GemPharmatech

1 follower

Coatue Management

11 followers

Signal AI

10 followers

Modern Executive Solutions

9 followers

Explore companies